DXS International plc Director/Pdmr Shareholding
22 Juni 2022 - 8:00AM
UK Regulatory
TIDMDXSP
DXS INTERNATIONAL PLC
Notification of Change of Significant Shareholding and
PDMR Dealing
("DXSP")
The Board of DXS International plc (the "Company"), the AQSE
Growth Market quoted healthcare information and clinical decision
support systems provider, has been notified that Mr Ron Rhodes has
made transfers in relation to his entire holding of 2,000,000
shares in the Company.
DL Services Limited, a company owned and controlled by the Chief
Executive's wife, has acquired 845,000 Ordinary Shares in the
Company at a price of 10p per share.
Following the transaction specified above Mr Immelman's
interests, including those of persons closely associated with him,
is 5,720,501 Ordinary Shares representing 11.85% of the issued
share capital of the Company.
Details of the person discharging managerial responsibilities
1 / person closely associated
--- -------------------------------------------------------------------------
DL Services Limited, a company owned
a) Name and controlled by Lorraine Immelman
--- ----------------------------- ------------------------------------------
2 Reason for the notification
--- -------------------------------------------------------------------------
Person closely associated with Chief
a) Position/status Executive Officer David Immelman
--- ----------------------------- ------------------------------------------
Initial notification
b) /Amendment Initial
--- ----------------------------- ------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
--- -------------------------------------------------------------------------
a) Name DXS INTERNATIONAL PLC
--- ----------------------------- ------------------------------------------
b) LEI 2138001R1KEUWTXEVJ44
--- ----------------------------- ------------------------------------------
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
4 have been conducted
--- -------------------------------------------------------------------------
Description of the financial
instrument, type of
a) instrument Ordinary Shares of 0.33p each
---
Identification code ISIN GB00B2Q6HZ92
b) Nature of the transaction Purchase
--- ----------------------------- ------------------------------------------
c) Price(s) and volume(s)
--- ------------------- ------------------
Price(s) Volume(s)
--- ------------------- ------------------
10p 845,000
----------------------------------------------------- ------------------
d) Aggregated information
---
- Aggregated volume
- Price
e) Date of the transaction 6 June 2022
--- ----------------------------- ------------------------------------------
f) Place of the transaction Outside a trading venue
--- ----------------------------- ------------------------------------------
The Directors of DXS International plc accept responsibility for
this announcement
Contacts:
David Immelman (Chief Executive) 01252 719800
DXS International plc david@dxs-systems.com
www.dxs-systems.co.uk
Corporate Advisor
City & Merchant
David Papworth 020 7101 7676
Corporate Broker
Hybridan LLP
Claire Louise Noyce 020 3764 2341
About DXS:
DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other
trusted NHS sources, to doctors, nurses and pharmacists in their
workflow and during the patient consultation. This effective
clinical decision support ultimately translates to improved
healthcare outcomes delivered more cost effectively which should
significantly contribute towards the NHS achieving its projected
efficiency savings.
(END) Dow Jones Newswires
June 22, 2022 02:00 ET (06:00 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
DXS (AQSE:DXSP)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
DXS (AQSE:DXSP)
Historical Stock Chart
Von Jun 2023 bis Jun 2024